Print This Post
In a groundbreaking development, the MND-SMART trial, a cutting-edge clinical trial for motor neurone disease (MND), has received a significant boost in funding. MND Scotland and the MND Association, both prominent charities dedicated to supporting individuals and families affected by MND, have announced an additional investment of £2.5 million pounds to expedite the delivery of this crucial research initiative. This substantial financial commitment marks a significant step forward in the quest to find effective treatments for this devastating neurodegenerative condition.
The MND-SMART Trial stands as a beacon of hope in the pursuit of improved therapies and ultimately a cure for MND. This ambitious initiative, which commenced in recent years, aims to test multiple treatments simultaneously, significantly accelerating the process of identifying potential breakthroughs. By employing this novel “platform trial” approach, researchers can evaluate the efficacy of various drugs and interventions in parallel, optimising the chances of discovering effective treatments for MND.
With the generous infusion of £2 million pounds from MND Scotland and £500,000 from MND Association, the MND-SMART trial will continue its operations, expanding its impact and gathering further evidence for these potentially life-altering drugs. This additional funding will facilitate the recruitment of participants, allowing for robust data collection and will enable the trial to continue to explore a range of treatment options for this currently incurable disease.s.
The success of the MND-SMART trial is underpinned by the collaborative efforts of researchers, clinicians, industry partners, and charitable organisations like MND Scotland, MND Association and the My Name’5 Doddie Foundation. Through pooling resources, expertise, and insights, these stakeholders are forging a united front against MND, fostering an environment of shared knowledge and accelerated progress.
As the MND-SMART trial progresses with renewed vigor, the collective hopes of the MND community are buoyed by this significant investment. News of the launch of the UK MND Research Institute along with this groundbreaking research initiative means there is immense promise for individuals living with MND, their families, and the broader medical community. It is a testament to the power of collaboration, determination, and the unwavering commitment to finding effective treatments and, ultimately, a cure for MND.
You will find further information on MND-SMART in this blog from the MNDA.
This week Dementia Researcher is shining a spotlight on MND Research, to find out more about the MND-SMART Trial, join our livestream (or watch the recording) on our YouTube Channel – 12noon, 23rd June 2023
Dr Sam Moxon
